This study is testing whether a once-nightly medication called FT218 can help control excessive daytime sleepiness in people with idiopathic hypersomnia. About 150 participants will take either the medication or a placebo for approximately 18 weeks to see if it improves their abi…
Phase: PHASE3 • Sponsor: Avadel • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC